A classification using CRP and AFP in predicting survival of early- and intermediate-stage HCC treated with TACE
Our findings suggest that CRP-AFP classification serves as a simple and effective prognostic tool for post-TACE early- and intermediate-stage HCC patients.
Authors
- Manabu Hayashi (ORCID: https://orcid.org/0000-0002-2213-3918)
- Masashi Fujita (ORCID: https://orcid.org/0000-0002-1457-6233)
- Yosuke Takahata
- Tatsuro Sugaya (ORCID: https://orcid.org/0000-0002-8703-6078)
- Kazumichi Abe (ORCID: https://orcid.org/0000-0001-5359-9465)
- Hiromasa Ohira (ORCID: https://orcid.org/0000-0003-4331-0634)
- Atsushi Takahashi (ORCID: https://orcid.org/0000-0003-0568-8361)
- Naoto Abe
Institutions
- Fukushima Medical University (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1093/jjco/hyaf041
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32